About
CLEW uses artificial intelligence and data science to develop patient-level physiological predictive models. Originally developed and proven in the intensive care unit (ICU), the models are now being extended to all care settings, where they are used to assist healthcare providers in forecasting the state of their patients. Deployable from the patients bedside to a centralized command-and-control facility, CLEW is designed to help providers make better-informed clinical decisions, improve outcomes and safety, streamline patient care, better cope with increased regulation and penalties, lower the cost of care, and remove discharge barriers. CLEW is currently being deployed in ICUs across Israel and in the United States for telemedicine capabilities. In February 2021, the company received FDA clearance for its AI-based predictive analytics technology that supports patient assessment in adult intensive care units.